Periplocin

Periplocin is an activator of ATPases and AKT and related targets used in studies of PI3K-Akt-mTOR Signaling and MAPK / ERK Signaling. In practice, this places the compound in experiments that measure growth-factor signaling, survival control, and nutrient-sensing outputs and mitogenic kinase cascades, proliferation control, and differentiation-linked signaling in cancer, cell signaling, and metabolism models.

By activating ATPases and AKT and related targets, Periplocin can be used to examine growth-factor signaling, survival control, and nutrient-sensing outputs and mitogenic kinase cascades, proliferation control, and differentiation-linked signaling. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving ATPases and AKT and related targets
• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and MAPK / ERK Signaling
• Gain-of-function pathway-activation studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, Periplocin is appropriate when a defined chemical perturbant is needed to connect ATPases and AKT and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.